drugset
Drugs / VRC-FLUNPF081-00-VP
last change Sep 2019 re-read 3 minutes ago

VRC-FLUNPF081-00-VP

also known as HA-F A/Sing

Vaccine

Developed for
influenza
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1

today NCT03186781 · Ph 1
2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03186781 Oct 2017 → Sep 2019 influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as VRC-FLUNPF081-00-VP ClinicalTrials.gov intervention name — accepted as the source's own label NCT03186781 ↗
Known as HA-F A/Sing “VRC-FLUNPF081-00-VP (HA-F A/Sing) is an investigational influenza HA ferritin vaccine.” NCT03186781 ↗
Modality Vaccine “VRC-FLUNPF081-00-VP (HA-F A/Sing) is an investigational influenza HA ferritin vaccine.” NCT03186781 ↗
Route Intramuscular “Vaccines were administered intramuscularly (IM) in the deltoid muscle.” NCT03186781 ↗